@Kewpie saidIn fact that can't be derived from the study.
Is it the drug or the reduced body fat the reason for the fall in obesity associated cancers? I skimmed through the article but didn't see any discussion of this point.
This would need control groups who loose weight in another way.
@Ponderable
Doesn't that kind of suggest it may be a paper paid for by Pharm to increase sales of Ozempic?
@sonhouse saidNo. They just picked some low hanging fruit by doing a statistical evaluation of data that were available (no experimental work of their own). They do claim the research necessities. If I was to sepculate I would say they did this to get new reserach grants.
@Ponderable
Doesn't that kind of suggest it may be a paper paid for by Pharm to increase sales of Ozempic?
1 edit
@Ponderable
Well if it results in real data showing Ozempic lowers cancer rates maybe it will be worth it.
Of course any new data from those papers won't come out for years so it won't help right now.
And speaking of diabetes did you hear about the latest help for it, nano tech that has feedback about glucose levels, the molecule lowers the amount of insulin released if glucose is low and increases the release of insulin if glucose levels are high? So the molecule itself senses and reacts to glucose levels.
That to me is astounding.
https://www.mdpi.com/2673-4591/56/1/56
I first read about this in phys.org a couple months ago.